September 2, 2020 – Midmark Corp. (Dayton, OH) launched the Midmark Digital Spirometer, designed to make the detection and management of asthma, COPD, and other respiratory illnesses simple and effective.
The Midmark Digital Spirometer equips caregivers with the technology needed for early detection and management of asthma and COPD in patients. Spirometry testing is the most effective and common method for diagnosing COPD; it is also the recommended test for confirming asthma, Midmark says. Spirometry also can support disease management decisions and provide indication of how well treatments are working.
The Midmark spirometer works seamlessly with top electronic medical records (EMR) systems. The spirometry software will learn as it is used, intelligently populating patient race, age, sex and height (RASH) information from the EMR, then transferring test data back into the EMR to reduce transcription errors and missing reports.
The spirometer utilizes the GOLD (Global Initiative for Chronic Obstructive Lung Disease) classification for the diagnosis and management of COPD.